SCHEMBL670111

SCHEMBL670111

COC(=O)Nc1ccccc1C1C(C(=O)O)c2cc(OC)c(OC)cc2C(=O)N1C

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
KDM4E B2RXH2 4/20 0.65
KMT2A Q03164 3/20 0.65
CYP1A2 P05177 2/20 0.65
MEN1 O00255 2/20 0.65
CYP3A4 P08684 2/20 0.65
TSHR P16473 3/20 0.59
POLB P06746 2/20 0.58
HSD17B10 Q99714 2/20 0.58
RECQL P46063 1/20 0.58
MAPT P10636 2/20 0.56
MAPK1 P28482 1/20 0.54
PKM P14618 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
LMNA P02545 1/20 0.49
CYP2C9 P11712 2/20 0.48
ALOX15 P16050 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14990215 1.00 ALDH1A1 (0.65) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL14990216 1.00 ALDH1A1 (0.65) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL15003808 1.00 ALDH1A1 (0.65) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL10114213 0.93 ALDH1A1 (0.66) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL14990180 0.92 KMT2A (0.53) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL10114227 0.92 KMT2A (0.53) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL14990181 0.92 KMT2A (0.53) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL10114216 0.92 KMT2A (0.53) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL14999180 0.86 ALDH1A1 (0.49) ALDH1A1KDM4EKMT2ACYP1A2MEN1
SCHEMBL14999183 0.86 ALDH1A1 (0.49) ALDH1A1KDM4EKMT2ACYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073920-B2 Substituted dibenzonaphthyridines, pharmaceutical uses thereof and processes therfor PURDUE RESEARCH FOUNDATION (US) 2015-07-07 US disclosed
US-20130143878-A1 SUBSTITUTED DIBENZONAPHTHYRIDINES, PHARMACEUTICAL USES THEREOF AND PROCESSES THERFOR PURDUE RESEARCH FOUNDATION (US) 2013-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130143878-A1 SUBSTITUTED DIBENZONAPHTHYRIDINES, PHARMACEUTICAL USES THEREOF AND PROCESSES THERFOR KRAS, QDPR, BTD ALDH1A1 1798/4885KDM4E 3525/4885KMT2A 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.